Abstract No. 273 Balloon pulmonary angioplasty in patients with non-operable or residual chronic thromboembolic hypertension: initial 5-year experience in a national referral center

Balloon pulmonary angioplasty (BPA) has become an emerging and complementary strategy for chronic thromboembolic hypertension (CTEPH) patients who are not suitable for pulmonary endarterectomy (PEA) or present recurrent symptoms after PEA. The purpose of our study was to evaluate the efficacy and safety of BPA in patients with non-operable or residual CTEPH during the initial 5-year experience in a single national referral center.